{"id":"https://openalex.org/W2783170811","doi":"https://doi.org/10.1080/2162402x.2017.1423172","title":"A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma","display_name":"A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma","publication_year":2018,"publication_date":"2018-01-16","ids":{"openalex":"https://openalex.org/W2783170811","doi":"https://doi.org/10.1080/2162402x.2017.1423172","mag":"2783170811","pmid":"https://pubmed.ncbi.nlm.nih.gov/29721378"},"language":"en","primary_location":{"id":"doi:10.1080/2162402x.2017.1423172","doi":"https://doi.org/10.1080/2162402x.2017.1423172","is_oa":true,"landing_page_url":"https://doi.org/10.1080/2162402x.2017.1423172","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1423172?needAccess=true&role=button","source":{"id":"https://openalex.org/S2497914550","display_name":"OncoImmunology","issn_l":"2162-4011","issn":["2162-4011","2162-402X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoImmunology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1423172?needAccess=true&role=button","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083431383","display_name":"Meghan J. Mooradian","orcid":"https://orcid.org/0000-0002-8289-8015","observed_orcids":["https://orcid.org/0000-0002-8289-8015"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meghan J. Mooradian","raw_affiliation_strings":["Department of Medical Oncology, Massachusetts General Hospital, Boston, MA","Department of Medicine, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088889988","display_name":"Alexandre Reuben","orcid":"https://orcid.org/0000-0003-4510-0382","observed_orcids":["https://orcid.org/0000-0003-4510-0382"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandre Reuben","raw_affiliation_strings":["Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":"https://orcid.org/0000-0003-4510-0382","affiliations":[{"raw_affiliation_string":"Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036869327","display_name":"Peter A. Prieto","orcid":"https://orcid.org/0000-0003-3792-7355","observed_orcids":["https://orcid.org/0000-0003-3792-7355"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter A. Prieto","raw_affiliation_strings":["Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032871350","display_name":"Mehlika H. Hazar-Rethinam","orcid":"https://orcid.org/0000-0002-3619-7250","observed_orcids":["https://orcid.org/0000-0002-3619-7250"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mehlika Hazar-Rethinam","raw_affiliation_strings":["Department of Medical Oncology, Massachusetts General Hospital, Boston, MA","Department of Medicine, Harvard Medical School, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0002-3619-7250","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047185974","display_name":"Dennie Tompers Frederick","orcid":"https://orcid.org/0000-0003-3355-5267","observed_orcids":["https://orcid.org/0000-0003-3355-5267"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennie T. Frederick","raw_affiliation_strings":["Department of Medical Oncology, Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091239626","display_name":"Brandon Nadres","orcid":"https://orcid.org/0000-0002-4690-5978","observed_orcids":["https://orcid.org/0000-0002-4690-5978"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brandon Nadres","raw_affiliation_strings":["Department of Medical Oncology, Massachusetts General Hospital, Boston, MA","Department of Medicine, Harvard Medical School, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0002-4690-5978","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014864191","display_name":"Adriano Piris","orcid":"https://orcid.org/0000-0003-1081-9821","observed_orcids":["https://orcid.org/0000-0003-1081-9821"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adriano Piris","raw_affiliation_strings":["Department of Medicine, Harvard Medical School, Boston, MA","Department of Pathology, Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Department of Pathology, Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015055837","display_name":"Vikram R. Juneja","orcid":"https://orcid.org/0000-0001-6011-6417","observed_orcids":["https://orcid.org/0000-0001-6011-6417"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210092658","display_name":"Harvard\u2013MIT Division of Health Sciences and Technology","ror":"https://ror.org/00jjeh629","country_code":"US","type":"education","lineage":["https://openalex.org/I4210092658"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vikram Juneja","raw_affiliation_strings":["Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA","Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA","Harvard University and Massachusetts Institute of Technology, Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Harvard University and Massachusetts Institute of Technology, Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210092658","https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071770314","display_name":"Zachary Aaron Cooper","orcid":"https://orcid.org/0000-0003-1059-0940","observed_orcids":["https://orcid.org/0000-0003-1059-0940"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zachary A. Cooper","raw_affiliation_strings":["Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":"https://orcid.org/0000-0003-1059-0940","affiliations":[{"raw_affiliation_string":"Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044052948","display_name":"Arlene H. Sharpe","orcid":"https://orcid.org/0000-0002-9736-2109","observed_orcids":["https://orcid.org/0000-0002-9736-2109"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arlene H. Sharpe","raw_affiliation_strings":["Department of Medicine, Harvard Medical School, Boston, MA","Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA","Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030510204","display_name":"Ryan Bruce Corcoran","orcid":"https://orcid.org/0000-0001-8173-5778","observed_orcids":["https://orcid.org/0000-0001-8173-5778"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan B. Corcoran","raw_affiliation_strings":["Department of Medical Oncology, Massachusetts General Hospital, Boston, MA","Department of Medicine, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023174631","display_name":"Keith T. Flaherty","orcid":"https://orcid.org/0000-0002-3402-0478","observed_orcids":["https://orcid.org/0000-0002-3402-0478"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keith T. Flaherty","raw_affiliation_strings":["Department of Medical Oncology, Massachusetts General Hospital, Boston, MA","Department of Medicine, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049839632","display_name":"Donald P. Lawrence","orcid":"https://orcid.org/0000-0001-5288-9110","observed_orcids":["https://orcid.org/0000-0001-5288-9110"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Donald P. Lawrence","raw_affiliation_strings":["Department of Medical Oncology, Massachusetts General Hospital, Boston, MA","Department of Medicine, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035427219","display_name":"Jennifer Ann Wargo","orcid":"https://orcid.org/0000-0003-3438-7576","observed_orcids":["https://orcid.org/0000-0003-3438-7576"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer A. Wargo","raw_affiliation_strings":["Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008479799","display_name":"Ryan Joseph Sullivan","orcid":"https://orcid.org/0000-0001-5344-6645","observed_orcids":["https://orcid.org/0000-0001-5344-6645"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ryan J. Sullivan","raw_affiliation_strings":["Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX","Department of Medical Oncology, Massachusetts General Hospital, Boston, MA","Department of Medicine, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Department of Medical Oncology, Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5008479799"],"corresponding_institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I136199984","https://openalex.org/I4210087915"],"apc_list":{"value":2375,"currency":"GBP","value_usd":2913},"apc_paid":{"value":2375,"currency":"GBP","value_usd":2913},"fwci":1.4911,"has_fulltext":true,"cited_by_count":27,"citation_normalized_percentile":{"value":0.81800591,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"7","issue":"5","first_page":"e1423172","last_page":"e1423172"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vemurafenib","display_name":"vemurafenib","score":0.9750000238418579},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.9639999866485596},{"id":"https://openalex.org/keywords/high-dose-interleukin-2","display_name":"high-dose interleukin-2","score":0.8889999985694885},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.8820000290870667},{"id":"https://openalex.org/keywords/braf-v600e-mutation","display_name":"BRAF V600E mutation","score":0.9929999709129333},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6079999804496765},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.6809999942779541},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.6899999976158142},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.9340000152587891},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.8930000066757202},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8259999752044678},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.44999998807907104}],"concepts":[{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.9718406200408936},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7981002330780029},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.7877218723297119},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6979833841323853},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5153038501739502},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.47925472259521484},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45842069387435913},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.44380876421928406},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.26763150095939636}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1080/2162402x.2017.1423172","doi":"https://doi.org/10.1080/2162402x.2017.1423172","is_oa":true,"landing_page_url":"https://doi.org/10.1080/2162402x.2017.1423172","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1423172?needAccess=true&role=button","source":{"id":"https://openalex.org/S2497914550","display_name":"OncoImmunology","issn_l":"2162-4011","issn":["2162-4011","2162-402X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoImmunology","raw_type":"journal-article"},{"id":"pmid:29721378","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29721378","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncoimmunology","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:5335414","doi":null,"is_oa":false,"landing_page_url":"http://europepmc.org/pmc/articles/PMC5927481","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5927481","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5927481","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Oncoimmunology","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:3495f5ff5acd475a9e7884607e56d256","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/3495f5ff5acd475a9e7884607e56d256","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"OncoImmunology, Vol 7, Iss 5 (2018)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1080/2162402x.2017.1423172","doi":"https://doi.org/10.1080/2162402x.2017.1423172","is_oa":true,"landing_page_url":"https://doi.org/10.1080/2162402x.2017.1423172","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1423172?needAccess=true&role=button","source":{"id":"https://openalex.org/S2497914550","display_name":"OncoImmunology","issn_l":"2162-4011","issn":["2162-4011","2162-402X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoImmunology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8299999833106995,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2783170811.pdf","grobid_xml":"https://content.openalex.org/works/W2783170811.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W1565041471","https://openalex.org/W1950572133","https://openalex.org/W1965370740","https://openalex.org/W1985126564","https://openalex.org/W1985312995","https://openalex.org/W1997825389","https://openalex.org/W2019607817","https://openalex.org/W2052781279","https://openalex.org/W2071255079","https://openalex.org/W2076668534","https://openalex.org/W2080686146","https://openalex.org/W2096387850","https://openalex.org/W2103027517","https://openalex.org/W2103059688","https://openalex.org/W2103675014","https://openalex.org/W2114903025","https://openalex.org/W2116376943","https://openalex.org/W2124039716","https://openalex.org/W2127269011","https://openalex.org/W2128542677","https://openalex.org/W2135925159","https://openalex.org/W2139276825","https://openalex.org/W2139280421","https://openalex.org/W2154196978","https://openalex.org/W2166262263","https://openalex.org/W2169198176","https://openalex.org/W2232500106","https://openalex.org/W2337664219","https://openalex.org/W2418246656"],"related_works":["https://openalex.org/W1963703839","https://openalex.org/W2068993338","https://openalex.org/W2170839278","https://openalex.org/W4361919025","https://openalex.org/W2018028361","https://openalex.org/W2404580886","https://openalex.org/W3000278797","https://openalex.org/W4298861393","https://openalex.org/W2553114403","https://openalex.org/W2419568780"],"abstract_inverted_index":{"Background:":[0],"Approximately":[1],"50%":[2],"of":[3,60,85,153,225,244],"melanomas":[4],"harbor":[5],"BRAF":[6,10],"mutations.":[7],"Treatment":[8],"with":[9,16,31,34,73,119,167,174,189,208,235],"+/\u2212":[11],"MEK":[12],"inhibition":[13],"is":[14,203,249],"associated":[15,173,207],"favorable":[17],"changes":[18],"in":[19,45,97,162,182,196,216],"the":[20,25,128,148,212,223,228,242],"tumor":[21],"microenvironment":[22],"thus":[23],"providing":[24],"rationale":[26],"for":[27],"combining":[28,232],"targeted":[29],"agents":[30],"immunotherapy.Methods:":[32],"Patients":[33,53],"unresectable":[35],"Stage":[36],"III":[37],"or":[38],"IV":[39],"BRAFV600E":[40,164],"mutant":[41],"melanoma":[42],"were":[43,54,155],"enrolled":[44],"a":[46,193],"single-center":[47],"prospective":[48],"study":[49],"(n":[50],"=":[51],"6).":[52],"eligible":[55],"to":[56,90],"receive":[57],"two":[58],"courses":[59],"HD-IL-2":[61,190,202,213,248],"and":[62,83,110,124,201,206,241,247],"vemurafenib":[63,129,200,246],"twice":[64],"daily.":[65],"The":[66],"primary":[67],"endpoint":[68],"was":[69,95,105,135,144,158,172,187],"progression-free":[70],"survival":[71,78],"(PFS)":[72],"secondary":[74],"objectives":[75],"including":[76],"overall":[77],"(OS),":[79],"response":[80],"rates":[81],"(RR),":[82],"safety":[84],"combination":[86,170,245],"therapy":[87,171,237],"as":[88],"compared":[89],"historical":[91],"controls.":[92],"Immune":[93],"profiling":[94],"performed":[96],"longitudinal":[98],"tissue":[99],"samples,":[100],"when":[101],"available.Results:":[102],"Overall":[103],"RR":[104],"83.3%":[106],"(95%":[107,138],"CI:":[108,139],"36%\u201399%)":[109],"66.6%":[111],"at":[112,150],"12":[113],"weeks.":[114,160],"All":[115],"patients":[116,154],"eventually":[117],"progressed,":[118],"three":[120,125],"progressing":[121,126],"on":[122],"treatment":[123,209],"after":[127],"continuation":[130],"phase":[131],"ended.":[132],"Median":[133,142],"PFS":[134],"35.8":[136],"weeks":[137],"16\u201357":[140],"weeks).":[141],"OS":[143],"not":[145],"reached;":[146],"however,":[147],"time":[149],"which":[151],"75%":[152],"still":[156],"alive":[157],"104.4":[159],"Change":[161],"circulating":[163],"levels":[165],"correlated":[166],"response.":[168],"Though":[169],"enhanced":[175],"CD8":[176],"T":[177,184],"cell":[178,185],"infiltrate,":[179],"an":[180],"increase":[181,215],"regulatory":[183],"frequency":[186],"seen":[188],"administration,":[191],"suggesting":[192],"potential":[194,220],"limitation":[195],"this":[197],"strategy.Conclusion:":[198],"Combination":[199],"well":[204],"tolerated":[205],"responses.":[210],"However,":[211],"induced":[214],"Tregs":[217],"may":[218],"abrogate":[219],"synergy.":[221],"Given":[222],"efficacy":[224],"regimens":[226,234],"targeting":[227],"PD-1":[229],"pathway,":[230],"strategies":[231],"these":[233],"BRAF-targeted":[236],"are":[238],"currently":[239],"underway,":[240],"role":[243],"uncertain.Trial":[250],"Registration:":[251],"Clinical":[252],"trial":[253],"information:":[254],"NCT01754376;":[255],"https://clinicaltrials.gov/show/NCT01754376":[256]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":4}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}